From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy

Y Qian, E Feldman, S Pennathur, M Kretzler… - Diabetes, 2008 - Am Diabetes Assoc
Progression of diabetic nephropathy to end-stage kidney disease is mediated by a host of
pro-cesses, but none is as important as the gradual, inexorable scarring of the renal …

TGF-β in renal fibrosis: triumphs and challenges

YY Gu, XS Liu, XR Huang, XQ Yu… - Future Medicinal …, 2020 - Taylor & Francis
Renal fibrosis is a hallmark of chronic kidney disease. Although considerable achievements
in the pathogenesis of renal fibrosis have been made, the underlying mechanisms of renal …

Cellular and molecular mechanisms in kidney fibrosis

JS Duffield - The Journal of clinical investigation, 2014 - Am Soc Clin Investig
Fibrosis is a characteristic feature of all forms of chronic kidney disease. Deposition of
pathological matrix in the interstitial space and within the walls of glomerular capillaries as …

Murine Precision-Cut Kidney Slices as an ex vivo Model to Evaluate the Role of Transforming Growth Factor-β1 Signaling in the Onset of Renal Fibrosis

EGD Stribos, MA Seelen, H van Goor, P Olinga… - Frontiers in …, 2017 - frontiersin.org
Renal fibrosis is characterized by progressive accumulation of extracellular matrix (ECM)
proteins, resulting in loss of organ function and eventually requiring renal replacement …

Role of matrix metalloproteinases in degenerative kidney disorders

S Narula, C Tandon, S Tandon - Current medicinal chemistry, 2018 - ingentaconnect.com
Matrix metalloproteinases (MMPs) are members of calcium dependent-zinc containing
endopeptidases that play a pivotal role in extracellular matrix (ECM) remodeling. MMPs are …

Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseases

M Papasotiriou, F Genovese… - Nephrology Dialysis …, 2015 - academic.oup.com
Background The extent of renal fibrosis in chronic kidney disease (CKD) is the best predictor
for progression of most renal diseases. To date, no established biomarkers of renal fibrosis …

Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease

O Zakiyanov, M Kalousová, T Zima, V Tesař - Advances in Clinical …, 2021 - Elsevier
Matrix metalloproteinases (MMPs) are a group of zinc and calcium endopeptidases which
cleave extracellular matrix (ECM) proteins. They are also involved in the degradation of cell …

Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related molecules

J Tang, F Liu, ME Cooper, Z Chai - Expert opinion on therapeutic …, 2022 - Taylor & Francis
Introduction Diabetic kidney disease (DKD) is the most common cause of end-stage renal
disease (ESRD) worldwide. Currently, there is no effective treatment to completely prevent …

The role of the macrophage-to-myofibroblast transition in renal fibrosis

J Wei, Z Xu, X Yan - Frontiers in Immunology, 2022 - frontiersin.org
Renal fibrosis causes structural and functional impairment of the kidney, which is a dominant
component of chronic kidney disease. Recently, a novel mechanism, macrophage-to …

Fibrosis and cancer: Shared features and mechanisms suggest common targeted therapeutic approaches

L Landolt, GC Spagnoli, A Hertig… - Nephrology Dialysis …, 2022 - academic.oup.com
Epidemiological studies support a strong link between organ fibrosis and epithelial cancers.
Moreover, clinical and experimental investigations consistently indicate that these diseases …